Grant: Planning and Dissemination Grant - Institute Community Support
McGill University
$8,500.00
Understanding experiences of using medical cannabis in different regulatory contexts: planning an international qualitative study
FY 2016-17
Summary
The use of medical marijuana is growing given scientific evidence that it helps to relieve chronic pain due to illness, disability or side-effects of treatments. Canada was the first country to legalize medical marijuana in 2001 and many other countries have since followed suit, although there is wide variation in how production, access, and use of medical marijuana is managed within and across countries. Very few studies have explored patient's perspectives on using medical marijuana. Our team of clinicians, researchers, patients and policy makers, including international collaborators in UK, USA, Australia, Germany and Israel (countries where medical marijuana is legal), would like to collect and share people's stories of using medical marijuana when living with chronic pain. In this one-year planning project, we will: 1) summarize the existing research on personal experiences of using medical marijuana; 2) review the policies and programs related to medical marijuana use in each of our participating countries; 3) find existing patient stories within our international collaboration on health experiences (see: www.dipexinternational.org) about using medical marijuana for further review (e.g. from studies of different health topics, such as breast cancer); and 4) prepare a formal proposal to collect patient experiences in these countries so that we can compare and contrast patient experiences across different contexts. We will publish the results of this work in a scientific journal, and submit a research proposal to a funding organization such as CIHR. We believe that a better understanding of the diversity of patient experiences will help inform the development and implementation of policy and practice, provide educational material for healthcare professionals, and help support individual patients and families. We can also learn about best practices and innovation from cross-country comparisons of patient experience and government policies and programs.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
365767
Name
Law Susan K
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Health systems / services
Prcname2
Planning and Dissemination - IMHA
Projecttitle
Understanding experiences of using medical cannabis in different regulatory contexts: planning an international qualitative study
Programtype2
Miscellaneous Programs
Orgnameinp2
McGill University
Cihramount2
$8,500
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
International Study; Medical Cannabis; Patient Experiences; Qualitative Research
Abstract
The use of medical marijuana is growing given scientific evidence that it helps to relieve chronic pain due to illness, disability or side-effects of treatments. Canada was the first country to legalize medical marijuana in 2001 and many other countries have since followed suit, although there is wide variation in how production, access, and use of medical marijuana is managed within and across countries. Very few studies have explored patient's perspectives on using medical marijuana. Our team of clinicians, researchers, patients and policy makers, including international collaborators in UK, USA, Australia, Germany and Israel (countries where medical marijuana is legal), would like to collect and share people's stories of using medical marijuana when living with chronic pain. In this one-year planning project, we will: 1) summarize the existing research on personal experiences of using medical marijuana; 2) review the policies and programs related to medical marijuana use in each of our participating countries; 3) find existing patient stories within our international collaboration on health experiences (see: www.dipexinternational.org) about using medical marijuana for further review (e.g. from studies of different health topics, such as breast cancer); and 4) prepare a formal proposal to collect patient experiences in these countries so that we can compare and contrast patient experiences across different contexts. We will publish the results of this work in a scientific journal, and submit a research proposal to a funding organization such as CIHR. We believe that a better understanding of the diversity of patient experiences will help inform the development and implementation of policy and practice, provide educational material for healthcare professionals, and help support individual patients and families. We can also learn about best practices and innovation from cross-country comparisons of patient experience and government policies and programs.
Competitiondate
201702
Approvedterm2
1 yr 0 mth
Pinamesdelim
Law, Susan K; Ware, Mark A
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Musculoskel Hlth &Arth~ $8,500~ $0~